News | Ultrasound Imaging | August 23, 2019

Exo Imaging Raises $35 Million for Developmental Ultrasound Platform

Startup aims to provide an affordable portable ultrasound platform with high image fidelity, penetration depth and 3-D imaging

Exo Imaging Raises $35 Million for Developmental Ultrasound Platform

August 23, 2019 — Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on piezoelectric micromachined ultrasonic transducers (pMUT) and artificial intelligence (AI) for imaging and therapeutic applications.

Exo (pronounced “Echo”) is bringing diagnostic-grade medical imaging to the pocket of every caregiver and clinician worldwide, according to the company. It is developing an affordable medical ultrasound platform capable of exceptional image fidelity, penetration depth and 3-D imaging that still fits in the palm of your hand.

The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging.

The company was founded in 2015 and has raised nearly $50M to date. Intel Capital led the Series B. Other investors in Exo include: Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Magnetar Capital, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Sony Innovation Fund and Wanxiang Healthcare Investments.

Exo CEO Sandeep Akkaraju said the Series B financing will enable the company to advance its products through the U.S. Food and Drug Administration (FDA) 510(k) clearance process and into commercialization. The company will use the proceeds to build out its team of engineering, sales and operations professionals. 

For more information: www.exo-imaging.com

Related Content

Videos | Ultrasound Imaging | August 13, 2020
This is a tutorial video on how to perform an ...
GE Healthcare Vscan with artificial intelligence (AI) automated left ventricular ejection fraction assessment with the Dia LVivo EF app. #ASE2020 #AI

GE Healthcare Vscan with artificial intelligence (AI) automated left ventricular ejection fraction assessment with the Dia LVivo EF app.

News | Cardiovascular Ultrasound | August 12, 2020
August 12, 2020 — GE focused on the latest innovations from the handheld ultrasound,...
Building on its commitment to providing customers with artificial intelligence (AI) solutions that can be utilized across modalities in routine care, Canon Medical Systems USA, Inc. is partnering with Zebra Medical Vision to offer its AI1 automated imaging analysis solutions to help clinicians in the U.S. provide faster, accurate diagnoses for optimized patient care
News | Artificial Intelligence | August 11, 2020
August 11, 2020 — Building on its commitment to providing customers with...
Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of mammography systems to Hologic’s state-of-the-art imaging technology
News | Breast Imaging | August 06, 2020
August 6, 2020 — RadNet, Inc., a national leader in providing hig
Franco Fontana, CEO of the Esaote Group, and Xie Yufeng, Chairman of WDM.

Franco Fontana, CEO of the Esaote Group, and Xie Yufeng, Chairman of WDM.

News | Digital Radiography (DR) | July 31, 2020
July 31, 2020 — In the thick of the COVID-19 eme
Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

News | Prostate Cancer | July 28, 2020
July 28, 2020 — A study published in